Table 2.
Baseline clinical characteristics of hospitalized older adults in Togo in 2019 (N = 650)
| Total (N = 650) |
< 60 years (N = 274) |
≥ 60 years (N = 376) |
p-value | |
|---|---|---|---|---|
| Length of stay (days) | 0.085* | |||
| Median (IQR) | 17 (8–32) | 20 (10–34) | 16 (8–32) | |
| Type of hospitalization services, n(%) | 0.178** | |||
| Medical | 494 (76.0) | 201 (73.4) | 293 (77.9) | |
| Surgical | 156 (24.0) | 73 (26.6) | 83 (22.1) | |
| Health pyramid level of hospital, n(%) | 0.739** | |||
| Tertiary | 566 (87.1) | 240 (87.6) | 326 (86.7) | |
| Secondary | 84 (12.9) | 34 (12.4) | 50 (13.3) | |
| Comorbidities | ||||
| Diabetes, n(%) | 124 (19.1) | 37 (13.5) | 87 (23.1) | 0.002** |
| Hypertension, n(%) | 290 (44.6) | 105 (38.3) | 185 (49.2) | 0.006** |
| Other cardiovascular diseases, n(%) | 87 (13.4) | 33 (12.0) | 54 (14.4) | 0.238** |
| Osteoarthritis, n(%) | 51 (7.8) | 16 (5.8) | 35 (9.3) | 0.104** |
| Other comorbidities, n(%) | 24 (3.7) | 6 (2.2) | 18 (4.8) | 0.511** |
| Number of comorbidities, n(%) | < 0.001** | |||
| 0 | 262 (40.3) | 131 (47.8) | 131 (34.8) | |
| 1 | 254 (39.1) | 104 (38.0) | 150 (39.9) | |
| ≥ 2 | 134 (20.6) | 38 (14.2) | 95 (25.3) | |
| Functional impairment, n(%) | 0.015** | |||
| None | 506 (77.8) | 226 (82.5) | 280 (74.5) | |
| Moderate/Severe | 144 (22.2) | 48 (17.5) | 96 (25.5) | |
| Main diagnoses during hospitalization | ||||
| Malnutrition, n(%) | 0.003** | |||
| No | 26 (4.0) | 18 (6.4) | 8 (2.1) | |
| Yes | 494 (76.0) | 204 (74.5) | 290 (77.1) | |
| MD | 130 (20.0) | 52 (19.0) | 78 (20.8) | |
| Depression, n(%) | 0.440** | |||
| No | 233 (35.8) | 98 (35.8) | 135 (35.9) | |
| Yes | 317 (48.8) | 145 (52.9) | 172 (45.7) | |
| MD | 100 (15.4) | 31 (11.3) | 69 (18.4) | |
| HIV, n(%) | 0.001** | |||
| Negative | 539 (83.0) | 211 (77.0) | 328 (87.2) | |
| Positive | 38 (5.8) | 26 (9.5) | 12 (3.2) | |
| MD | 73 (11.2) | 37 (13.5) | 36 (9.6) | |
| Other cardiovascular diseasesa, n(%) | 111 (17.1) | 41 (15.0) | 70 (18.6) | 0.222** |
| Other infectionsb, n(%) | 91 (14.0) | 44 (16.1) | 47 (12.5) | 0.197** |
| Stroke, n(%) | 81 (12.5) | 28 (10.2) | 53 (14.1) | 0.174** |
| Malignant diseases, n(%) | 75 (11.5) | 29 (10.6) | 46 (12.2) | 0.516** |
| Fractures and injuries, n(%) | 66 (10.2) | 40 (14.6) | 26 (6.9) | 0.001** |
| Gastrointestinal diseases, n(%) | 53 (8.2) | 23 (8.4) | 30 (8.0) | 0.848** |
| Renal diseases, n(%) | 49 (7.5) | 16 (5.8) | 33 (8.8) | 0.161** |
| Diabetes mellitus, n(%) | 31 (4.8) | 6 (2.2) | 25 (6.6) | 0.008** |
MD Missing data, *Wilcoxon-Mann-Whitney; **Chi square test
aOther cardiovascular diseases: Cardiomyopathy, congestive heart failure, hypertension
bOther infections: Rhinopharyngitis, Influenza and Pneumopathy